Health
SARS-CoV-2 Neucleocapside (N) protein is heavily glycosylated – News-Medical.Net
However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint server bioRxiv in August 2020 reveals the structure of this protein, a val…
Eight months into the COVID-19 pandemic, there is still no fully protective therapy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has infected millions worldwide. Vaccines are being worked on in a host of institutions and countries, mostly targeting the spike protein of the virus. However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint s…
-
General21 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News18 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025